Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104035
Filing Date
2025-08-06
Accepted
2025-08-06 16:12:53
Documents
71
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imnm-20250630.htm   iXBRL 10-Q 2437329
2 EX-10.1 imnm-ex10_1.htm EX-10.1 504275
3 EX-10.2 imnm-ex10_2.htm EX-10.2 76400
4 EX-10.3 imnm-ex10_3.htm EX-10.3 61038
5 EX-31.1 imnm-ex31_1.htm EX-31.1 16847
6 EX-31.2 imnm-ex31_2.htm EX-31.2 16831
7 EX-32.1 imnm-ex32_1.htm EX-32.1 10314
8 EX-32.2 imnm-ex32_2.htm EX-32.2 10495
  Complete submission text file 0000950170-25-104035.txt   8614468

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT imnm-20250630.xsd EX-101.SCH 908736
73 EXTRACTED XBRL INSTANCE DOCUMENT imnm-20250630_htm.xml XML 1241690
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 251189713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)